Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Current Taxes (2016 - 2025)

Ascendis Pharma A's Current Taxes history spans 7 years, with the latest figure at $2.5 million for Q4 2023.

  • For Q4 2023, Current Taxes fell 55.84% year-over-year to $2.5 million; the TTM value through Dec 2023 reached $2.5 million, down 55.84%, while the annual FY2023 figure was $2.5 million, 57.02% down from the prior year.
  • Current Taxes for Q4 2023 was $2.5 million at Ascendis Pharma A, down from $5.6 million in the prior quarter.
  • Across five years, Current Taxes topped out at $5.6 million in Q4 2022 and bottomed at $131719.6 in Q4 2019.
  • The 5-year median for Current Taxes is $358879.2 (2020), against an average of $1.8 million.
  • The largest annual shift saw Current Taxes surged 2372.85% in 2022 before it crashed 55.84% in 2023.
  • A 5-year view of Current Taxes shows it stood at $131719.6 in 2019, then skyrocketed by 172.46% to $358879.2 in 2020, then crashed by 36.89% to $226506.2 in 2021, then soared by 2372.85% to $5.6 million in 2022, then plummeted by 55.84% to $2.5 million in 2023.
  • Per Business Quant, the three most recent readings for ASND's Current Taxes are $2.5 million (Q4 2023), $5.6 million (Q4 2022), and $226506.2 (Q4 2021).